Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 21;39(11):1343–1357. doi: 10.1177/0333102419864132

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© International Headache Society 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 8. — Lasmiditan-treated migraine attacks by quarter in patients with a maximum of two, three, and four quarters of data available (safety population).

L100: lasmiditan 100 mg; L200: lasmiditan 200 mg; Q1: quarter 1 (months 0–3); Q2: quarter 2 (months 3–6); Q3: quarter 3 (months 6–9); Q4: quarter 4 (months 9–12). The figure includes data for patients who had two quarters, three quarters, and four quarters of data available.